Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Vodafone agrees €30m Romanian deal

(Sharecast News) - Vodafone Group is to ramp up its presence in Romania, the London-listed telecoms giant confirmed on Friday, after striking a €30m deal with Hellenic Telecommunications Organization. The blue chip said Vodafone Romania and rival Digi Romania had entered into binding agreements with the Greek company.

Under the deal, Vodafone will acquire parts of Hellenic's subsidiary, Telekom Romania Mobile Communications (TRMC) - Romania's fourth-largest operator with around 3.8m subscribers - and its post-paid customer base for €30m.

Digi, meanwhile, has agreed to acquired its pre-paid customer business.

Both companies will also gain additional spectrum and towers under the deal.

As at 1130 BST, shares in Vodafone were up 2% at 86p.

Margherita Della Valle, Vodafone chief executive, said: "This transaction strengthens our position in Romania by increasing our local scale and unlocking significant synergy benefits.

"It supports our strategy of building strong positions in growing markets, which enables us to invest in high-quality networks."

The deal, which will reduce the number of operators in Romania to three, is due to complete next month. The three parties first started discussions just under a year ago.

Hellenic has been looking to offload its Romanian assets for some time.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.